Abstract：Objective To investigate the risk factors for early disseminated intravascular coagulation (DIC) in neonates with sepsis. Methods A retrospective clinical study was performed on 100 neonates with a confirmed diagnosis of sepsis between 2012 and 2013. The children were classified into normal coagulation group, non-overt DIC group (early DIC group), and overt DIC group (late DIC group) based on the ISTH overt DIC scoring system. The clinical manifestations and risk factors were analyzed statistically. Results Early DIC occurred in 44 (44%) cases in the 100 neonates with sepsis. The incidence of sclerema showed significant differences between the three groups (P<0.05). Asphyxia, bleeding, and Gram-negative bacterial infection were independent risk factors for early DIC. Conclusions Coagulation function should be actively monitored and early intervention measures should be taken for neonates with asphyxia, bleeding, and Gram-negative bacterial infection to prevent early DIC from progressing to late DIC.
WANG Wen-Hua,XU Ding,HAN Ya-Mei et al. Risk factors for early disseminated intravascular coagulation in neonates with sepsis[J]. CJCP, 2015, 17(4): 341-344.
Oren H, Cingoz I, Duman M, et al. Disseminated intravascular coagulation in pediatric patients: clinical and laboratory features and prognostic factors influencing the survival[J]. Pediatr Hematol Oncol, 2005, 22(8): 679-688.
Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis[J]. Pediatr Clin North Am, 2013, 60(2): 367-389.
[15]
Pichler E, Pichler L. The neonatal coagulation system and the vitamin K deficiency bleeding-a mini review[J]. Wien Med Wochenschr, 2008, 158(13-14): 385-395.
Strunk T, Currie A, Richmond P, et al. Innate immunity in human newborn infants: prematurity means more than immaturity[J]. J Matern Fetal Neonatal Med, 2011, 24(1): 25-31.
[18]
Bauman ME, Cheung PY, Massicotte MP. Hemostasis and platelet dysfunction in asphyxiated neonates[J]. J Pediatr, 2011, 158(2 Suppl): e35-e39.
Levi M, van der Poll T. The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients[J]. Semin Thromb Hemost, 2008, 34(5): 459-468.
[21]
Zeckey C, Andruszkow H, Neunaber C, et al. Protective effects of finasteride on the pulmonary immune response in a combined model of trauma-hemorrhage and polymicrobial sepsis in mice[J]. Cytokine, 2011, 56(2): 305-311.
[22]
Schroeder JE, Weiss YG, Mosheiff R. The current state in the evaluation and treatment of ARDS and SIRS[J]. Injury, 2009, 40(Suppl 4): S82-S89.
